Vaso Corp
- Close
- Sep 4, 2026
- Market cap
- $54.57M
- 176.02M shares
- Filings
- 509
Q3 2026+2.7% FY25 yoy
Q3 2026+65.0% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derived+87.2% FY22 yoy
Q3 2026±0.0% FY25 yoy
Q3 2026+29.7% FY25 yoy
- $54.57M
- 22.2×
- 0.8×
- 1.8×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Sep 4, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $89,096,000 | reported | |
| FY 2024 | 2024-12-31 | $86,767,000 | reported | |
| FY 2023 | 2023-12-31 | $81,024,000 | reported | |
| FY 2022 | 2022-12-31 | $79,294,000 revised | reported | |
| FY 2021 | 2021-12-31 | $75,579,000 | reported | |
| FY 2020 | 2020-12-31 | $69,850,000 | reported | |
| FY 2019 | 2019-12-31 | $75,515,000 revised | reported | |
| FY 2018 | 2018-12-31 | $73,980,000 | reported | |
| FY 2017 | 2017-12-31 | $72,788,000 | reported | |
| FY 2016 | 2016-12-31 | $72,589,000 | reported | |
| FY 2015 | 2015-12-31 | $57,082,000 | reported | |
| FY 2014 | 2014-12-31 | $34,954,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2015 | — | $0.00 | $0.00 | — | 158.44M sh | +1.5% | 0.0% |
| FY2014 | — | $245.00K | $245.00K | — | 156.14M sh | −0.1% | 11.1% |
| FY2013 | — | $1.76M | $1.76M | — | 156.22M sh | −4.1% | — |
| FY2012 | — | $0.00 | $0.00 | — | 162.98M sh | +2.7% | 0.0% |
Segments
LineFY2025ShareChange
Professional Sales Service Segment$44.19M50%+6.9%
Professional sales services$44.19M50%+6.9%
IT Segment$42.47M48%−1.1%
Equipment$2.44M2.7%−1.5%
Equipment Segment$2.44M2.7%−1.5%
Equipment Sales and Services———
Equipment Segment———
Other———
Total$89.10M
Electromedical & electrotherapeutic apparatus
Vaso Corp is the 9th largest of the 31 covered companies the SEC files under this code, by revenue. SIC 3845
CompanyRevenueGrowthNet marginMarket cap
AXGNAxogen, Inc.$225.2M20.2%7.0%$3.0BOMOutset Medical, Inc.$119.5M5.1%68.3%$73.4M
VASOVaso Corp (this company)$89.1M2.7%1.8%$54.6M
CBLLCeribell, Inc.$89.1M36.1%60.0%$1.1BELMDElectromed, Inc.$73.8M15.3%15.3%$234.0MFOCLEdap TMS SA$70.5M1.6%41.5%$162.9MIRIXIridex Corp$52.7M8.2%8.4%$11.8MSTXSStereotaxis, Inc.$32.4M20.3%66.8%$85.5MECORelectroCore, Inc.$32.0M27.2%43.6%$48.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Vaso Corp · CIK 839087 · Engraved from SEC EDGAR